is semaglutide in shortage FDA Ends Listing, Contributing to Ongoing Legal Challenges Addressing the Weight Loss Injectable

For example, taurine therapy has been explored as an adjunct in cardiovascular diseases (such as congestive heart failure and hypertension) and metabolic or liver disorders (including high cholesterol and chronic hepatitis), and even in supportive treatment of cystic fibrosis

say they are seeing a steep increase in calls related to semaglutide, an injected medication used for diabetes and weight loss, with some people reporting symptoms related to accidental overdoses

491 By regulating appetite, insulin secretion, and lipid metabolism, GLP-1RAs have potential benefits in the treatment of NAFLD, NASH, and T2DM

This shift introduces a new challenge for R&D teams: sterilization as a constraint that can influence what types of therapies are feasible to develop and deliver